Odyssey Health (ODYY) Convertible Debt (2025)
Odyssey Health (ODYY) posted quarterly Convertible Debt of $1.7 million for Q4 2025, up 4.8% quarter-over-quarter from $1.6 million in Q3 2025.
Odyssey Health (ODYY) Convertible Debt (2025) Analysis & Trends
Odyssey Health's Convertible Debt history runs 1 years deep, the most recent figure standing at $1.7 million for Q4 2025.
- In Q4 2025, Convertible Debt changed N/A year-over-year to $1.7 million; the TTM figure through Oct 2025 stood at $1.7 million (changed N/A YoY), while the FY2025 annual figure was $1.6 million, changed N/A from the prior year.
- Convertible Debt for Q4 2025 stood at $1.7 million, up from $1.6 million in the prior quarter.
- The five-year high for Convertible Debt was $1.7 million in Q4 2025, with the low at $1.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 202.72 Bn | 197.12 Bn | 7.27 Bn |
| 2 | Stryker | 126.42 Bn | 122.94 Bn | 4.50 Bn |
| 3 | Medtronic | 119.75 Bn | 110.53 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.13 Bn | 73.60 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.78 Bn | 47.53 Bn | 1.35 Bn |
| 6 | Dexcom | 35.29 Bn | 33.34 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.95 Bn | 31.85 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.22 Bn | 22.90 Bn | 4.55 Bn |
| 9 | Steris | 23.21 Bn | 22.73 Bn | 684.20 Mn |
| 10 | Odyssey Health | 1.01 Mn | 711,880.61 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | 1.66 Mn |
| Jul 31, 2025 | 1.58 Mn |